Biomolecular wearable apparatus

ABSTRACT

This invention relates to an apparatus that regulates thermodynamic energy-flow within a human body for producing beneficial effects such as, for example, improvement in strength, improvement in stamina, pain relief, etc. According to one embodiment, the invention provides a wearable apparatus that may include biomolecular components for building-up of a thermomagnetic energy within the human body. According to another embodiment, the invention provides a wearable apparatus that may include biomolecular components for dilution of a thermomagnetic energy within the human body. According to yet another embodiment, the invention provides a wearable apparatus that may include biomolecular components having orthomolecular and/or non-orthomolecular organic materials which are capable of thermomagnetic levororotary action and/or thermomagnetic dextrorotatory action.

CROSS REFERENCE TO RELATED APPLICATIONS

This application claims priority from U.S. provisional patentapplication Ser. No. 60/413,617, filed on Sep. 25, 2002, which isincorporated by reference in its entirety.

FIELD OF THE INVENTION

This invention relates generally to a biomolecular wearable apparatusregulating energy-flow, and more particularly to a biomolecular wearableapparatus regulating thermomagnetic energy flow within human body forproducing beneficial effects including an improvement in stamina and arelief from a pain.

BACKGROUND OF THE INVENTION

Jewelries including ring, necklace, bracelets, and pendants aretypically used for decorative purpose. However, there is a segment ofthe jewelry market that concerns itself for a purpose other thandecorative. Examples of jewelries that are designed for the purposeother than decorative include copper bracelets and magnetic jewelries.

Copper bracelet is believed to perform functions of relieving pain andhelping to alleviate symptoms of arthritis for a user. A mode ofoperation for these functions has been proposed as mobility of copperions from the copper bracelet through the user's skin and into theuser's blood stream. If the mobility of copper ions is the mode ofoperation of a copper bracelet, then an individual or a user could notobtain immediate relief from pain, etc., due to a long period of timerequired for this mode of operation to become effective. Accordingly, adrawback of existing systems with respect to a copper bracelet is thatthe therapeutic response—if any—takes place over a relatively longperiod of time. Another drawback of the existing systems is that thecopper bracelets have a limited and narrow field of use.

Various types of magnetic jewelries are believed to perform functions ofrelieving pain and improving circulation. Clinical studies performedwith magnetic jewelries indicated that there is an effect going on otherthan a placebo effect. An effect of a magnet on a human body could bedue, in part, to the fact that human blood contains iron. In one theory,the iron in the blood causes the blood to be attracted to a part of thebody in which the magnet is worn, resulting in improvement incirculation. However, there are biophysicists who question the efficacyof a magnetic jewelry. For example, it is well known that the DNAcontains Hydrogen bonds. Because a magnet is polar in nature, a back emffrom the magnet to the Hydrogen bonds may be possible. This might causethe hydrogen to spin in opposition to what is normal and disassemble theDNA of that cell. In any case, long term studies of magnets as theyapply to humans are needed. Another drawback of the existing systemswith respect to a magnetic jewelry, is that the therapeutic response—ifany—is limited and narrow with respect to the field of use.

Therefore, with respect to jewelries that may be utilized for thepurpose of achieving a therapeutic effect, there is a need for analternative to the copper bracelet and the magnetic jewelries that arefound in the present market. Such alternative may require a mode ofoperation that is different from the modes of operation of the existingcopper bracelet and magnetic jewelries. In this regard, an examinationof alternative modes of operation for a passive therapeutic jewelryneeds to be considered.

First, referring to eastern philosophies, and specifically the Indianbelief of a human CHAKRA SYSTEM, a representation of what is referred toin eastern medicine and philosophy as the human Chakra system isdescribed. According to eastern philosophy, the human Chakras are pointsin the body in which a vortex-like flow reversal occurs, establishing astrong energy point in the human body. Like acupuncture, the concept ofa “Chakra” system in human beings has not been embraced by conventionalwestern medicine. However, it is interesting to note that the Chakrapoints do coincide with acupuncture points. Furthermore, the Chakrapoint of the Heart (#4, Anahata/Anandakanda) has special relevance tothe invention disclosed here.

Referring now to publicly available HUMAN ACUPUNCTURE CHARTS, arepresentation of various human acupuncture and acupressure points aredescribed. Unlike the “Chakra” concept, acupuncture has had someacceptance in western medicine, although this acceptance has onlyhappened over a period of decades. As may be seen in Acupuncture Charts,there is a strong Chi (energy) point at the same point as the #4 Chakra.This is known as the Shanzhong point, and is indicative of the primaryenergy flow point in the human body. For further clarification, thispoint is located on the anterior midline, at the level of the fourthintercostals space. An additional point of interest is the Zhongjipoint, located 4 cm below the umbilicus, and is indicative of thecrossing point of the ren channel. This is not to say that there are notadditional points of interest in the acupuncture system.

Referring now to the work of Davis and Rawls (Magnetism and its effecton the living system by Albert Roy Davis and Walter C. Rawls, April1996, Acres USA Publications), a view has been illustrated for actualelectrical measurements made on the front surfaces of a human body.These measurements were performed by Albert Roy Davis and Walter Rawlsat the Albert Roy Davis Research Laboratory in Florida. The findings ofthese two researchers indicate that the right side of the human body ispositively (electrically) charged and the left side of the human body isnegatively charged. These findings also indicate the average voltagesthat were recorded at various locations of the human body. It is worthnoting that the vicinity of the #4 Chakra point shows the highestvoltage among all the points on the human body. This would also coincidewith the belief in the acupuncture system that the Shanzhong point isthe strongest Chi point in the human body.

Referring again to Rawls and Davis (Magnetism and its effect on theliving system by Albert Roy Davis and Walter C. Rawls, April 1996, AcresUSA Publications), a view has been illustrated for the electromagneticequators of the human body. Of interest with respect to the inventiondisclosed here is the point in the center of the chest, which Davis andRawls state that according to their findings, this point is wherevoltage change is noted, ant at this point there is zero voltage whenmeasuring from the crotch to this point. Again, this corresponds wellwith the Chakra system and the acupuncture system.

In addition, the body of evidence supporting acupuncture has reached thepoint of being irrefutable. This said, a conclusion may be reached thatin addition to blood flowing through the human body, there is also anenergy flow through the human body.

In order to understand the energy flow through the human body, aphenomenon of a thermomagnetic field may need to be considered. Athermomagnetic field may be obtained when a group of dissimilar metalsis arranged so as to form a coil, with each dissimilar metal junctionbeing alternately heated and cooled. To illustrate this effect,reference is now made to the work of Schroeder, with publicly titleddocuments (U.S. Pat. No. 5,393,350 and U.S. Pat. No. 5,597,976) entitledTHERMOELECTRIC GENERATOR AND MAGNETIC ENERGY STORAGE UNIT invented bySchroeder. In operation, this device is capable of obtaining a lowvoltage, high current within the ring structure resulting in a magneticfield of 10 to 20 tesla. The magnetic field produced is so strong thatthe ring requires structural reinforcement with Keviar or the like. Thepoint made here is that this device produces a magnetic field in a novelmanner, a method that does not use an electrical input but rather aninput of heat.

Referring now to FIG. 1, a human body as illustrated relates totemperature differential. As illustrated in FIG. 1, human beingsmaintain a core temperature that is higher with respect to theextremities of the hands and feet. This differential is well known inthe art and may be viewed in detail via infrared imaging techniques wellknown to those of skilled in the art. Due to this temperaturedifferential as well as other factors, the conditions necessary for theproduction of thermomagnetic fields within the human body may bepresent. This phenomenon is scientifically plausible when one considerstemperature differential, the presence of dissimilar metal components inthe body such as Iron (blood) and Copper (collagen, enzymes, etc.), andthe manner in which the blood flows via the circulatory system (flowreversals at extremities). In eastern philosophy, the thermomagneticfield is referred to as the “Aura”, and is shown to extend severalinches from the body. This would be consistent with magnetism.Furthermore, Kirlian photography technique records a field of energyemanating several inches from humans and plants, again consistent withmagnetic fields.

If there is indeed a magnetic energy field that extends from the surfaceof a human body, then it should be possible to construct a passiveapparatus that would be capable of interacting with this field, andaltering the properties of this field. As an example, in acupuncture, apractitioner utilizes known techniques to detect “blockages” to energyflows in the human body. When the locations of these blockages aredetermined, then either needles or pressure is applied to this point forthe purpose of relieving and removing the blockages. Accordingly,another drawback of the existing systems is a lack of an apparatus thatcan be placed over specific acupuncture points and that can interactwith a humans' energy field and promote energy flow and circulation in asimilar mode of operation to acupuncture but without needles or physicalcontact.

When considering the flow of either fluids or energy, we now considervortex flows that consist of either centripetal or centrifugal forces,and how these flows might be produced passively. As will be recalled, avortex may have an inward spiraling flow (centripetal) or an outwardspiraling flow (centrifugal). In nature, the tornado is an example of aphenomena that illustrates both flow types. Further, it is often statedthat an inward spiraling vortex is associated with a build-up of energy,such as the destructive tip of the tornado, while an outward spiralingvortex is associated with a dilution of energy.

Various chemical species in the human body and biochemical materials mayalso need to be considered since they may play a role in interactingwith energy fields within the human body. To this end, Left-Handed andRight-Handed molecules may need to be considered. It is known that theLeft-Handed group of molecules known as amino acids are utilized in thebody for the purpose of building protein structures such as muscletissue. This process of the amino acid forming a “building block” for alarger protein structure is generally recognized as being a solelychemical process. However, if all naturally occurring amino acids areconsidered Left-Handed (amino acids are isomers and demonstrate thephenomena of optical chirality), and the light passing through an aminoacid will bend to the left, a thermomagnetic field in the presence of anL-amino acid would orient itself to the left as well. Accordingly, atthe molecular level, in the process of the amino acid being used to forma protein, the human thermomagnetic field twists to the left in thepresence of the L-amino acid, causing the thermomagnetic field to spinclockwise (inward) which creates a buildup of energy, with this energyassisting in the formation of the new protein structure.

Similarly, some sugars such as sucrose may play a role in the humanbody. Common table sugar is a right-handed molecule. Thus, the humanthermomagnetic field in the presence of sugar would spincounter-clockwise thereby creating a centrifugal flow which would leadto the dissipation of an energy field. This would at first seem to beinconsistent with the role that sugar plays in the body, which would beto create the basic building blocks of energy units (ATP). However, ifwe examine the actual chemical process that sugar is involved in, thenwe know that in order for sugar to enter the ATP cycle, it must first bebroken down. Accordingly, at the molecular level, in the process of thesugar being broken down so that it may be used for the creation of ATP,the human thermomagnetic field twists to the right in the presence ofthe sugar, causing the thermomagnetic field to spin counter-clockwise(outward) which creates a dissipation of the structure, with this energyassisting in the destruction of the sugar molecule.

If these effects are occurring within the human body, then it should bepossible to create a device that passively interacts with the human bodyin such a way so as to promote the build-up or flow of energy within thehuman body.

Therefore, another drawback of the existing system is a lack of anapparatus and a method for regulating the energy-flow, thereby producinga beneficial response within the human body.

These and other drawbacks also exist.

SUMMARY OF THE INVENTION

The invention overcomes these and other drawbacks.

In one embodiment, the invention provides an apparatus that produces abeneficial effect when placed on a human body. In some embodiments, thebeneficial effect may include, for example, strength increase, staminaincrease, pain relief, etc.

In one embodiment, the invention provides an apparatus that regulatesthermomagnetic energy flow within a human body.

In one embodiment, the invention provides an apparatus that produces abeneficial effect when placed on a human body, wherein the apparatusregulates thermodynamic energy-flow within the human body for producingthe beneficial effect.

In one embodiment, the invention provides an apparatus that includesbiomolecular components for regulating thermomagnetic energy flow withina human body. In one embodiment, the biomolecular components may includemolecules associated with building-up of energy (e.g., thermomagneticenergy). In another embodiment, the biomolecular components may includemolecules associated with dilution of energy (e.g., thermomagneticenergy). In yet another embodiment the biomolecular components mayinclude molecules associated with building-up of energy (e.g.,thermomagnetic energy) and dilution of energy (e.g., thermomagneticenergy). In a further embodiment, the biomolecular components mayinclude orthomolecular and/or non-orthomolecular organic materialscapable of thermomagnetic levororotary action and/or thermomagneticdextrorotatory action.

In one embodiment, the invention provides an apparatus includingbiomolecular components associated with building-up of energy, whereinthe biomolecular components may include, for example, but not limited toa Left-Handed molecule such as an amino acid (e.g., L-Glutamine).

In one embodiment, the invention provides an apparatus includingbiomolecular components associated with dilution of energy, wherein thebiomolecular components may include, for example, but not limited to aRight-Handed molecule such as sugar, D-Glutamic acid, etc.

In one embodiment, the invention provides an apparatus including one ormore substrates, for example, but not limited to a polyester, cottonlabor sheet, etc., for biomolecular components that regulatethermomagnetic energy flow within a human body.

In one embodiment, the invention provides an apparatus including asealed plastic enclosure, wherein the sealed plastic enclosure mayenclose biomolecular components regulating thermomagnetic energy flowwithin a human body and one or more substrates for the biomolecularcomponents.

In one embodiment, the invention provides an apparatus that includes asealed plastic enclosure having biomolecular components regulatingthermomagnetic energy flow within a human body and one or moresubstrates for the biomolecular components, wherein the apparatusfurther includes one or more gem stones (e.g., Jade, powered jade, etc.)for decorative purpose.

In one embodiment, the invention provides one or more physicalstructural settings for holding components of an apparatus. In someembodiments, said one or more physical structural settings may holdbiomolecular components regulating thermomagnetic energy flow within ahuman body, one or more substrates for said biomolecular components, andone or more gem stones (e.g., Jade, powdered jade, etc.) for decorativepurpose.

In one embodiment, the invention provides an apparatus that produces abeneficial effect, for example improvement in strength/stamina, whenplaced on a human body, wherein the apparatus may comprise one or moreof components including, for example, Left-Handed molecules (e.g.,L-Glutamine), one or more substrates (e.g., a polyester, cotton fabricsheet, etc.) for said Left-Handed molecules, a sealed enclosure (e.g.,plastic film enclosure) enclosing said Left-Handed molecules and saidone or more substrates, one or more gem stones or similar materials(e.g., jade, etc.).

In one embodiment, the invention provides an apparatus that produces abeneficial effect, for example relief from a pain, when placed on ahuman body, wherein the apparatus may comprise one or more of componentsincluding, for example, Right-Handed molecules (e.g., sucrose,D-Glutamic acid, etc.), one or more substrates (e.g., a polyester,cotton fabric sheet, etc.) for said Right-Handed molecules, a sealedenclosure (e.g., plastic film enclosure) enclosing said Right-Handedmolecules and said one or more substrates, one or more gen stones orsimilar materials (e.g., jade, etc.).

In one embodiment, the invention provides an apparatus that may be inone or more of a plurality of wearable objects such as dermal patches,bracelets, pendants, support pads, shirts, socks, foot inserts, etc.

In some embodiments, the invention provides a non-transdermal patchhaving Left-Handed molecules for improving strength/stamina for a user.According to the invention, the non-transdermal patch having Left-Handedmolecules may be manufactured with the following specification:

500 mg of L-Glutamine is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Glutamine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

In other embodiments, the invention provides a non-transdermal patchhaving Right-Handed molecules for relieving from a pain for a user.According to the invention, the non-transdermal patch havingRight-Handed molecules may be manufactured with the followingspecifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

In one embodiment, the invention provides a method for fabricating anapparatus that produces a beneficial effect when placed on a human body,wherein the apparatus regulates thermomagnetic energy-flow within thehuman body for producing the beneficial effect.

In one embodiment, the invention provides a method for placing anapparatus on a human body or into a human body, wherein the apparatusproduces a beneficial effect when placed on the human body or into thehuman body, wherein the apparatus regulates thermomagnetic energy-flowwithin the human body for producing the beneficial effect.

Other objects and features of the invention will become apparent fromthe following detailed description considered in connection with theaccompanying drawings that disclose embodiments of the invention. Itshould be understood, however, that the drawings are designed forpurposes of illustration only and not as a definition of the limits ofthe invention.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates temperature differential in a human body.

FIG. 2A illustrates an example of an apparatus including a single layerfabric substrate for retaining biomolecular components, according to anembodiment of the invention.

FIG. 2B illustrates an example of a sealed apparatus including a singlelayer fabric substrate for retaining biomolecular components, accordingto an embodiment of the invention.

FIG. 3A illustrates an example of an apparatus including a multi-layerfabric substrate for retaining biomolecular components, according to anembodiment of the invention.

FIG. 3B illustrates an example of a sealed apparatus including amulti-layer fabric substrate for retaining biomolecular components,according to an embodiment of the invention.

FIG. 4 illustrates an example of a patch including a biomolecularapparatus that causes a beneficial effect within a human body, accordingto an embodiment of the invention.

FIG. 5 illustrates an example of a bracelet including a biomolecularapparatus that causes a beneficial effect within a human body, accordingto an embodiment of the invention.

FIG. 6 illustrates an example of a ring including a biomolecularapparatus that causes a beneficial effect within a human body, accordingto an embodiment of the invention.

FIG. 7 illustrates an example of a watch including a biomolecularapparatus that causes a beneficial effect within a human body, accordingto an embodiment of the invention.

DETAILED DESCRIPTION OF THE INVENTION

According to one embodiment, the invention provides an apparatus thatproduces a beneficial effect when placed on a human body, wherein theapparatus regulates thermodynamic energy-flow within the human body forproducing the beneficial effect. In some embodiments, the beneficialeffect may include, for example, strength increase, stamina increase,and pain relief.

According to another embodiment, the invention provides an apparatusthat may include biomolecular components for regulating thermomagneticenergy flow within a human body. In one embodiment, the biomolecularcomponents may include molecules associated with building-up of energy(e.g., thermomagnetic energy). In another embodiment, the biomolecularcomponents may include molecules associated with dilution of energy(e.g., thermomagnetic energy). In yet another embodiment, thebiomolecular components may include molecules associated withbuilding-up of energy (e.g., thermomagnetic energy) and dilution ofenergy (e.g., thermomagnetic energy). In a further embodiment, thebiomolecular components may include orthomolecular (e.g., naturallyoccurring organic compounds) and/or non-orthomolecular organic materialscapable of thermomagnetic levororotary action and/or thermomagneticdextrorotatory action.

According to another embodiment, the invention provides an apparatusthat may include orthomolecular organic compounds (e.g., naturallyoccurring organic compounds) and or non-orthomolecular organic compoundsfor inducing one or more beneficial effects such as, for example,strength increase, stamina increase, pain relief, etc.

Some of the orthomolecular and non-orthomolecular organic compounds maybe more fully described as complex organic structures with asymmetriccarbon atoms capable of either thermomagnetic levorotatory action due tothe proton pulling forces associated with thermomagnetic fields orthermomagnetic dextrorotatory action due to the proton pulling forcesassociated with thermomagnetic fields. In both cases, according to oneembodiment of the invention, the orthomolecular and/or nonorthomolecularorganic materials utilized may be arranged parallel with respect to theplane of thermomagnetic rotation.

According to another embodiment, the invention provides an apparatus,wherein the apparatus functions on the basis of the principle that theproton pulling forces associated with human thermomagnetic fields arecapable of interacting with passive orthomolecular and ornon-orthomolecular organic materials so long as these materials arearranged parallel to the plane of rotation, with this arrangementinducing electron flow due to well known and long establishedelectromotive principles.

It is known that hemoglobin is an Iron-containing pigment of red bloodcells. Its function is to carry Oxygen from the lungs to other tissues.It is also known that collagen is a Copper containing, fibrous insolubleprotein in connective tissues, including skin, bone, ligaments andcartilage. In addition, human beings possess a natural temperaturedifferential from the core to the extremities.

In physics, the Seebeck effect describes a phenomena in which when anapparatus consists of two metals (such as Iron and Copper), with onemetal at a higher temperature than the other, a current flows in theapparatus. The Thomson thermoelectric effect is the designation of thepotential gradient along a conductor which accompanies a temperaturegradient.

The thermomagnetic phenomena arises in that the thermoelectric andthermomagnetic power is measured by electromotive force produced by theunit difference of temperature, in this case the temperaturedifferential from the core to the extremities. In short, all of theconditions necessary for human beings to produce thermomagnetic fieldsare present in humans.

According to another embodiment, the invention provides a passiveapparatus that includes orthomolecular and non-orthomolecular organiccompounds for improving one or more beneficial effects (e.g., strength,stamina, human performance, etc.) by interacting with a humanthermomagnetic field. This interaction may induce an increased electronflow within a human body. In some embodiments, this interaction is notunlike the effect that occurs in an electrical generator in whichelectricity is produced from moving magnets or magnetic fields.

In humans, an increase in electron flow has numerous demonstrablebenefits with one being an immediate and measurable increase in physicalstrength. This is not a chemically induced increase in strength such aswould be the case with anabolic steroids, etc., but rather a phenomenain which existing muscle mass is utilized more efficiently due to theincrease in electron flow.

To understand how this phenomena could be possible, if we examine thestriated skeletal muscle apparatus we know that this voluntary groupnerve supply is under conscious control because these nerves arebranches of the peripheral cerebrospinal nervous apparatus (the brainand spinal cord as the cerebrospinal axis), The muscle fibers themselvesare tissues composed of contractile cells that effect movement based onthe excitatory process set up in nerve fibers by stimuli (the nerveimpulse). It is presently believed by medical research that the nerveimpulse is probably in the nature of a wave of electrochemicaldisturbances. The efficiency with which the nerve impulse controls aspecific muscle group can be defined as the number of muscle fibersutilized in a contraction divided by the number of fibers present inthat muscle group. It is presently believed that most humans onlycontract a small percentage of muscle fibers in a given group for agiven nerve impulse (low efficiency of muscle mass usage per nerveimpulse contraction).

If now we were to induce a condition in which the total power of theelectrochemical nerve impulse could be increased so that more musclefibers could contract for a given nerve impulse, the net efficiency ofthe striated fibers would increase (more muscle fibers in a group beingcontracted for a nerve impulse), and hence usable physical strengthcould be improved. This is one possible explanation for the phenomenaassociated with beneficed effects, for example, immediate anddemonstrable increases in strength and stamina within seconds of wearingthe wearable apparatus of the present invention.

This phenomena is not unusual or unknown in other devices. For example,in physical therapy electrical signals are utilized for the purpose offorcing voluntary muscle groups to contract under stimulation. Thesedevices are commonly known as electrical or electronic musclestimulators (EMS) and cause stimulated contraction and relaxation phasesof muscle groups. According to another embodiment, the inventionprovides an apparatus for, based on the mode of operation as presented,an improvement in net efficiency of total muscle mass utilized during acontraction phase that may be achieved due to an increase in electronflow during the wave of electrochemical disturbances created by thenerve impulse.

According to another aspect, the invention provides an apparatus thatpassively modulates the oscillating low energy magnetic field thatexists just above the surface of the human epidermal layer. This passivefrequency modulation creates a condition in which the transport of longchain fatty acids across the mitochondrial membrane for subsequentbeta-oxidation and energy production is triggered or improved, therebyproviding a user of the apparatus with increased energy via an increasein ATP production as described above.

To understand this phenomenon, the metabolic process involving fattyacid energy sources within the human body can be examined. Fatty acids,a hydrocarbon in which one of the hydrogen atoms has been replaced by acarboxyl group, are also described as a monobasic aliphatic acid made upof an alkyl radical attached to a carboxyl group. The metabolic role offatty acids may be described in part in that fatty acids are one of theprimary sources of energy for humans and, through Beta-Oxidation, arebroken down into basic units of energy. Of interest here is that, inorder for this process to work, fatty acids need to enter themitochondria for Beta-Oxidation, and they are unable to penetrate theinner mitochondrial membrane by themselves. In the human body, toovercome the problem of the inability of fatty acids to transport fromthe cytosol (soluble portion of the cell) across the mitochondrialmembrane, it has been determined by several researchers that variousnutrients are essential to transport long chain fatty acids from thecytosol across the mitochondrial membrane for fatty acidoxidation/metabolism and energy production.

According to the invention, in order to obtain the desirable effect ofimproving cell metabolism passively (specifically, increasing the rateof fatty acid Beta-Oxidation by allowing fatty acids to transport acrossthe mitochondrial membrane), an apparatus consisting of orthomolecularorganic structures can be designed to passively interact with the humanmagnetic field for the purpose of creating a system of frequencymodulation, much in the same way that radio waves are modulated tocommunicate audio information.

According to an embodiment of the invention, an apparatus 100 thatcauses a beneficial effect by regulating thermomagnetic energy-flowwithin a human body are illustrated in FIGS. 2A, 2B, 3A, and 3B.

According to another embodiment, the invention provides apparatus 100comprising biomolecular components that may include molecules associatedwith building-up of energy (e.g., thermomagnetic energy). In someembodiments, biomolecular components may include a Left-Handed moleculesuch as, for example, an amino acid. In one embodiment, the apparatusmay include a structure that may be used for promoting the flow ofenergy (electrons) within a human body so as to improve physicalstrength of a user, wherein the structure may include a Left-Handedmolecule such as, for example, an amino acid.

The Left-Handed amino acids are known in those skilled in the art, andas such a complete description of the Left-Handed amino acids need notbe given here, but suffice it to say that suitable Left-Handed aminoacids for use in the invention may include, for example, L-Glutamine,L-Arginine, L-Ornithine, L-Carnitine, L-Taurine, L-Tryptophan,L-Glycine, etc. Preferably, the amino acids used in the invention areorthomolecular amino acids.

In some embodiments, the Left-Handed molecule is an amino acid found innature. In other embodiments, the Left-Handed molecule is an amino acidsynthesized by man. The example of amino acids may include, but nolimited to, L-Alanine, L-Arginine, L-Aspargine, L-Aspartic Acid,L-Carnitine, Acetyl-L-Carnitine, L-Carnitine L-Tartrate, L-CarnitineMagnesium Citrate, L-Citrulline, L-Cystine, L-Cystine, L-GABA,L-Glutamic Acid, L-Glutamine, Glutathione Peroxidase, L-Glycine,L-Histidine, Hydroxyglutamic Acid, Hydroxyproline, L-Isoleucine,L-Leucine, Norleucine, L-Lysine, LMethionine, L-Ornithine, L-Valine,L-Phenylalanine, L-Proline, L-Serine, L-Taurine, L-Threonine,L-Tryptophan, L-Tyrosine, etc. In some embodiments, the Left-Handedmolecules may include a synthetic L-sugar (L-glucose) or other syntheticlevo-rotatory molecule known to one skilled in the art.

According to another embodiment of the invention, the Left-Handedmolecule may be employed in a variety of ways. In one example, thebiomolecular components including the Left-Handed molecules may be usedin the form of a liquid, with said liquid being sprayed or similarlyapplied to a substrate. In another example, the biomolecular componentsincluding the Left-Handed molecule may be used in the form of a solid,such as a powder, with said powder being mixed with a binder such aslatex rubber, silicone rubber, epoxy, wax or the like, with the powderedamino acid and binder being applied to a substrate.

According to another embodiment, the invention may include a structurethat includes a plurality of Left-Handed molecules. In other words, morethan one kind of Left-Handed molecules may be utilized in a structure.In one example, a structure in which L-glutamine may be applied to asingle substrate, followed by the layering of a second amino acid suchas L-Arginine to a second substrate, with both treated substratesforming part of the completed structure of the invention. In someembodiments, portions of L-Glutamine and L-Arginine may be mixedtogether, and then applied in the form of a liquid or powder to a singlesubstrate. In another example, two or more L amino acids may be appliedto the same substrate.

According to another embodiment, the invention provides an apparatuscomprising biomolecular components that may include molecules associatedwith dilution of energy (e.g., thermomagnetic energy). In someembodiments, the biomolecular components may include Right-Handedmolecules such as, for example, an amino acid. In one embodiment, theapparatus may include a structure that may be used for negating flow ofenergy (electrons) within a human body so as to decrease physicalstrength of a user or relax the user, wherein the structure may includeRight-Handed molecules such as, for example, an amino acid or sugar.

The Right-Handed amino acids and Right-Handed sugars are known to thoseskilled in the art, and as such a complete description of thesematerials need not be given here, but suffice it to say that suitableRight-Handed amino acids (i.e., D Amino acids) for use in the presentinvention may include, for example, D-Glutamine, D-Arginine,D-Ornithine, D-Carnitine, D-Taurine, D-Tryptophan, D-Glycine, D-GlutamicAcid, etc.

In some embodiments, the Right-Handed molecule is an amino acid found innature. In other embodiments, the Right-Handed molecule is an amino acidsynthesized by man. The Examples of the Right-Handed molecule mayinclude, but not limited to, D-Alanine, D-Arginine, D-Aspargine,D-Aspartic Acid, D-Carnitine, Acetyl-D-Carnitine, D-CarnitineD-Tartrate, D-Carnitine Magnesium Citrate, D-Citrulline, D-Cysteine,D-Cystine, D-GABA, D-Glutamic Acid, D-Glutamine, D-GlutathionePeroxidase, D-Glycine, D-Histidine, D-Hydroxyglutamic Acid,D-Hydroxyproline, D-Soleucine, D-Leucine, D-Norleucine, D-Lysine,D-Metbionine, D-Ornithine, D-Valine, D-Phenylalanine, D-Proline,S-Serine, D-Taurine, D-Threonine, D-Tryptophan, D-Tyrosine, etc.

According to another embodiment, the Right-Handed molecules may includeone or more sugars, for example, but not limited to dextrin, dextrose,fructose, galactose, glucose, glycogen, high fructose corn syrup, honey,inositol, invert sugar, lactose, levulose, maltose, molasses, sucrose,sugar cane, and xylose etc. Preferably, the Right-Handed amino acidsused in the invention are non-orthomolecular amino acids.

According to another embodiment of the invention, the Right-Handedmolecules may be employed in a variety of ways. In one example, thebiomolecular components including the Right-Handed molecules may be usedin the form of a liquid, with said liquid being sprayed or similarlyapplied to a substrate. In another example, biomolecular componentsincluding the Right-Handed molecules may be used in the form of a solid,such as a powder, with said powder being mixed with a binder such aslatex rubber, silicone rubber, epoxy, wax or the like, with the powderedamino acid and binder being applied to a substrate.

According to another embodiment, the invention may include a structurethat includes a plurality of Right-Handed molecules. In other words,more than one kind of Right-Handed molecules may be used in a structure.In one example, a structure in which D-Glutamic acid may be applied to asingle substrate, followed by the layering of a second D amino acid to asecond substrate, with both treated substrates forming part of thecompleted structure of the invention. In some embodiments, portions ofD-Glutamic acid and a second D amino acid may be mixed together, andthen applied in the form of a liquid or powder to a single substrate. Inanother example, two or more D amino acids may be applied to the samesubstrate.

According to another embodiment, the invention provides an apparatusincluding one or more substrates for the biomolecular componentsregulating thermomagnetic energy flow within a human body. In someembodiments, the one or more substrates may include, for example, butnot limited to a polyester fabric sheet, a cotton fabric sheet, etc. Inone embodiment, the one or more substrates may be used for theLeft-Handed molecules. In another embodiment, the one or more substratesmay be used for the Right Handed molecules. The one or more substratesmay not react (chemically, etc.) with the Left-Handed molecules and theRight-Handed molecules of the invention. The examples of substrates mayinclude, for example, but not limned to polyester fabric sheet (e.g.,manufactured by Pellon, # 910, an interfacing material for lightweightto featherweight fabrics, etc.), cotton fabric sheet, etc. In oneembodiment, either the polyester fabric sheet or the cotton fabric sheetmay be used in construction of the apparatus of the invention. Inanother embodiment, both the polyester fabric sheet and the cottonfabric sheet may be used in construction of apparatus 100 of theinvention.

According to another embodiment, the invention may include one or moreadditives for the Left-Handed molecules and/or Right-Handed molecules.The examples of additives may include, but not limited to Glycerin,d-calcium pantothenate, sorbitol, propylparaben, potassium sorbate,methylparaben, Colloidal Gold, etc.

According to another embodiment, the invention provides an apparatusincluding a sealed enclosure, wherein the sealed enclosure may enclosebiomolecular components (e.g., Left-Handed molecules, Right-Handedmolecules) regulating thermomagnetic energy flow within the human bodyand one or more substrates for the biomolecular components. The sealedenclosure may be made of a material, for example, but not limited to apolyester film sheet (e.g., manufactured by GBC, a thermal laminatingfilm, etc.), a plastic film (e.g., polyethylene, polypropylene, ABS,plexiglass, lexan, pvc, etc), etc. In one embodiment, the polyester filmsheet and/or the plastic film may be utilized in construction of theapparatus of the invention. In some embodiments the sealed enclosure maybe made of a light polarizing film. In other embodiments the sealedenclosure may be made of a linear low density film.

According to another embodiment of the invention, the sealed enclosuremay not react (i.e., chemically, etc.) with biomolecular components(e.g., Left-Handed molecules, Right-Handed molecules) of the invention.In some embodiments, the sealed enclosure may be capable of being sealedto a predefined fashion to keep the Left-Handed molecules and/or theRight-Handed molecules in a liquid state. In some embodiments, thesealed enclosure may be capable of being sealed in a predefined fashionto protect the Left-Handed molecules and/or the Right-Handed moleculesfrom ambient environmental conditions.

Methods of sealing plastic films are known to those skilled in the artand will not be described here in detail. Examples of such methods ofsealing plastic films may include, for example, pressure sensitive orthermally sensitive adhesives, ultrasonic sealing, etc.

According to another embodiment, the invention provides an apparatusthat includes a sealed plastic enclosure that encloses biomolecularcomponents regulating thermomagnetic energy flow within the human bodyand one or more substrates for the biomolecular components, wherein theapparatus further includes one or more gem stones (e.g., Jade, powderedjade, etc.).

In one embodiment, Jade may be used for decorative purposes, and for thepractice of the invention. Jade (or other gem stones) may beincorporated into the invention in either gem stone form, or in powderedform. If Jade is incorporated in stone form, then the apparatus of theinvention may be embodied as decorative items such as jewelry, etc. IfJade is incorporated in powdered form, then the Jade powder may be addedto the Left-Handed molecules and/or the Right-Handed molecules. The Jademay also be added in other parts of the devices of the invention so asto make the apparatus practical for use.

According to another embodiment, the invention provides one or morephysical structural settings for holding one or more components ofapparatus 100. In some embodiments, that the one or more physicalstructural settings may hold biomolecular components regulatingthermomagnetic energy flow within the human body, one or more substratesfor the biomolecular components, and one or more gem stones (e.g., Jade,powdered jade, etc.).

According to another embodiment, apparatus 100 may be in one or more ofa plurality of wearable objects, for example, but not limited to dermalpatches, bracelets, pendants, support pads, shirts, socks, foot inserts,etc.

According to another embodiment, the invention may include a patchhaving an adhesive (e.g., medical grade adhesive). In some embodiments,the invention may include a single patch. In other embodiments, theinvention may include a plurality of patches. In one embodiment, thepatch may be constructed in layers made of plastic film or lightpolarizing film, polyester fabric as a substrate, Water, L-Carnitine,Glycerin, d-calcium pantothenate, sorbitol, propylparaben, potassiumsorbate, and methylparaben. In another embodiment, the patch may beconstructed in layers made of a plastic film or a light polarizing filmas an enclosure, a polyester fabric as a substrate, Honey and Molasses.

If apparatus 100 of the present invention is embodied as jewelry items,then the apparatus may be mounted in virtually any jewelry setting thatis already commercially available, provided that the setting does notinterfere in any way with the operation of apparatus 100 of the presentinvention. If apparatus 100 of the invention is embodied in “Band Aid”style or “Transdermal Patch” style, then a setting would not be needed.In one embodiment, apparatus 100 of the invention may be completelysealed, thereby the Left-Handed molecules and/or the Right-Handedmolecules may not make direct contact with a user of apparatus 100. Inaddition, the Left-Handed molecules and/or the Right-Handed moleculesmay not enter into body of the user.

In some embodiments, Apparatus 100 of the invention having Left-Handedmolecules may be manufactured with the following specifications:

500 mg of L-Glutamine is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) ere cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Glutamine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

In other embodiments, Apparatus 100 of the invention having Right-Handedmolecules may be manufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

According to another embodiment, the invention provides a method forplacing apparatus 100 on a predetermined location of a human body orinto a human body, wherein apparatus 100 produces a beneficial effectwhen placed on the human body or into the human body, wherein apparatus100 regulates thermodynamic energy-flow within the human body forproducing the beneficial effect. The apparatus 100 may include, forexample, patch, bracelet, necklace, anklet, etc.

According to another embodiment, the invention provides methods forplacing apparatus 100 of the invention into proximity of a human body.In one example, apparatus 100 of the invention may be attached topendants, and allowed to be placed into proximity of the human body. Inanother example, apparatus 100 of the invention may be embodied in “BandAid” style or “Patch” style, with a medical grade adhesive being appliedto the device to make it suitable for use with human beings.

In one embodiment, apparatus 100 (e.g., dermal patch) may be placed onforearms of a user for producing a beneficial effect such as, forexample, improvement in strength or stamina. In some embodiments,apparatus 100 (e.g., dermal patch) having Left-Handed molecules may beplaced on the palm side of the right forearm of the user. In otherembodiments, apparatus 100 (e.g., dermal patch) having Right-Handedmolecules may be placed on the palm side of the left forearm of theuser.

For strength and stamina, apparatus 100 (e.g., dermal patch) may beplaced at Pericardium 4 (P4) located about 4 inches below the wrist.

For relief of sinus congestion, apparatus 100 (e.g., dermal patch) maybe placed on Large Intestine 14 (LI 14). In some embodiments, apparatus100 (e.g., dermal patch) having Left-Handed molecules may be placed onRIGHT shoulder and apparatus 100 (e.g., dermal patch) havingRight-Handed molecules may be placed on left shoulder for relief ofsinus congestion.

For relief of menstrual cramps, woman may place apparatus 100 (e.g.,dermal patch) having Left-Handed molecules at the depression on themidline of the chest and apparatus 100 (e.g., dermal patch) havingRight-Handed molecules at about 1-2 inches below the belly button (wherethe cramps are).

For relief of knee pain from arthritis, apparatus 100 (e.g., dermalpatch) having Left-Handed molecules may be placed along the midline atthe depression between the chest and apparatus 100 (e.g., dermal patch)having Right-Handed molecules may be placed where the pain is on theknee.

In a preferred embodiment, apparatus 100 (e.g., dermal patch) havingLeft-Handed molecules may be placed at an electrically POSITIVE point onthe body and apparatus 100 (e.g., dermal patch) having Right-Handedmolecules may be placed at an electrically NEGATIVE point on the body.Positive and Negative points on the body have been metered and been wellknown by physiologists for about 30 years+.

Furthermore, apparatus 100 (e.g., dermal patch) may be placed at knownacupuncture points. For example, apparatus 100 having Left-Handedmolecules (e.g., POSITIVE dermal patch) may be placed at a YANG(positive) point and apparatus 100 (e.g., dermal patch) havingRight-Handed molecule (e.g., NEGATIVE dermal patch) may be placed at aTIN (negative) point.

According to another embodiment of the invention illustrated in FIG. 2A,apparatus 100 that causes a beneficial effect (e.g., improvement instrength/stamina, relief from a pain, etc.) by regulating thermomagneticenergy flow within a human body may include a single layer fabricsubstrate 110 for retaining biomolecular components including, forexample, molecules tor building-up of energy (e.g., thermomagneticenergy) and/or molecules for dilution of energy (e.g., thermomageticenergy). Apparatus 100, as illustrated, may be fabricated in accordancewith the principles as described here in the preceding disclosure.

FIG. 2B illustrates a sealed single layer fabric substrate that retainthe biomolecular components.

According to another embodiment of the invention illustrated in FIG. 3A,apparatus 100 that causes beneficial effect (e.g., improvement instrength/stamina, relief from a pain, etc.) by regulating thermomagneticenergy-flow within a human body may include two layers of fabricsubstrate 120 for retaining biomolecular components including, forexample, molecules for building-up of energy (e.g., thermomagneticenergy) and/or molecules for dilution of energy (e.g., thermomagneticenergy). Apparatus 100, as illustrated, may be fabricated in accordancewith the principles as described here in the preceding disclosure.

FIG. 3B illustrates a sealed multi layer fabric substrate that retainthe biomolecular components.

According to another embodiment of the invention illustrated in FIG. 4,a patch 400 may include apparatus 100 for causing a beneficial effect(e.g., improvement in strength/stamina, relief from a pain etc.) for ahuman body by regulating thermomagnetic energy flow within the humanbody. In some embodiments, one or more portions of patch 400 may includemedical grade adhesive for enabling attachment of patch 400 to humanskin surface.

According to another embodiment of the invention illustrated in FIG. 5,a bracelet 500 may include apparatus 100 for causing a beneficial effect(e.g., improvement in strength/stamina, relief from a pain, etc.) for ahuman body by regulating thermomagnetic energy flow within the humanbody. In some embodiments, bracelet 500 may also include a gem stone(not shown in FIG. 5).

According to another embodiment of the invention illustrated in FIG. 6,a ring 000 may include apparatus 100 for causing a beneficial effect(e.g., improvement in strength/stamina, relief from a pain, etc.) for ahuman body by regulating thermomagnetic energy flow within the humanbody. In some embodiments, ring 600 may also include a gem stone 610.

According to another embodiment of the invention illustrated in FIG. 7,a watch 700 may include apparatus 100 for causing a beneficial effect(e.g., improvement in strength/stamina, relief from a pain, etc.) for ahuman body by regulating thermomagnetic energy flow within the humanbody.

EXAMPLES Example 1

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Carnitine is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. The interfacingmaterial is dipped in the L-Carnitine solution so as to saturate thefabric with the solution. The saturated fabric disk is then sandwichedand placed between 2 layers of the heat laminating film, and thestructure is sealed with a heating surface so as to form the completedstructure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) is utilized as the patch ingredient.A Pellon 100% polyester interfacing material is cut to a 1″ diameterdisk; GBC Heat Laminating films (# 3000038 clear polyester substratewith homopolymer adhesive) are cut to 1.69″ in diameter. The interfacingmaterial is dipped in the Honey so as to saturate the fabric with thesolution. The honey-saturated fabric disk is there sandwiched and placedbetween 2 layers of the heat laminating film, and the structure issealed with a heating surface so as to form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 15% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches.

Example 2

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Carnitine is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Carnitine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handled molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturateddisks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 15% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches. This formulation was utilized in the Morehouse College ClinicalStudy and the Troy State University Clinical Study.

Example 3

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Glutamine is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Glutamine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon1000% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 15% onaverage when using this formulation as opposed to not using thesepatches.

Example 4

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Carnitine is added to 15 ml of distilled water; To thissolution small amounts of preservatives are added so as to prevent theformation of mold or bacteria. In this case the preservatives that areadded are glycerin, potassium sorbate, methylparaben and propylparaben.A Pellon 100% polyester interfacing material is cut 1″ diameter disk;GBC Heat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Glutamine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of heat laminatingfilm (the saturated disks are separated from one another by plasticfilms), and the structure is sealed with a heating surface so as to formthe completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredients. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Headed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 15% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches.

Example 5

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Glutamine is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Glutamine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) seas increased ever 15% onaverage when using this formulation as opposed to not using thesepatches.

Example 6

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of acetyl-L-Carnitine is added to 15 ml of glycerin; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the acetyl-1-carnitine solution so asto saturate the fabrics with the solution. The saturated fabric disksare then sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 15% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 25% onaverage when using this formulation as opposed to not using thesepatches.

Example 7

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of acetyl-1-carnitine and 100 mg of L-Ornithine are added to 30ml of glycerin; A Pellon 100% polyester interfacing material is cut to1″ diameter disk; GBC Heat Laminating films (# 3000038 clear polyestersubstrate with homopolymer adhesive) are cut to 1.69″ in diameter. Twopieces of the interfacing material are dipped in the amino acid solutionso as to saturate the fabrics with the solution. The saturated fabricdisks are then sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 15% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 25% onaverage when using this formulation as opposed to not using thesepatches.

Example 8

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of acetyl-1-carnitine and 100 mg of L-Arginine are added to 30 mlof glycerin; A Pellon 100% polyester interfacing material is cut to a 1″diameter disk; GBC Heat Laminating films (# 3000038 clear polyestersubstrate with homopolymer adhesive) are cut to 1.69″ in diameter. Twopieces of the interfacing material are dipped in the amino acid solutionso as to saturate the fabrics with the solution. The saturated fabricdisks are then sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 15% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 25% onaverage when using this formulation as opposed to not using thesepatches.

Example 9

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Arginine is added to 15 ml of distilled water; A Pellon 100%polyester interfacing material is cut to a 1″ diameter disk; GBC HeatLaminating films (# 3000038 clear polyester substrate with homopolymeradhesive) are cut to 1.69″ in diameter. Two pieces of the interfacingmaterial are dipped in the L-Arginine solution so as to saturate thefabrics with the solution. The saturated fabric disks are thensandwiched and placed between separate layers of the heat laminatingfilm (the saturated disks are separated from one another by plasticfilms), and the structure is sealed with a heating surface so as to formthe completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches.

Example 10

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Ornithine is added to 15 ml of disliked water; A Pellon 100%polyester interfacing material is cut to 1″ diameter disk; GBC HeatLaminating films (# 3000038 clear polyester substrate with homopolymeradhesive) are cut to 1.69″ to diameter. Two pieces of the interfacingmaterial are dipped in the L-Ornithine solution so as to saturate thefabrics with the solution. The saturated fabric disks are thensandwiched and placed between separate layers of the heat laminatingfilm (the saturated disks are separated from one another by plasticfilms), and the structure is sealed with a heating surface so as to formthe completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 300038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches.

Example 11

Patch 400 of the invention having Left-Handed molecules may manufacturedwith the following specifications:

500 mg of L-Glutamic Acid is added to 15 ml of distilled water; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Glutamic Acid solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# A 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased ever 15% onaverage when using this formulation as opposed to not using thesepatches.

Example 12

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Glycine is added to 15 ml of distilled water; A Pellon 100%polyester interfacing material is cut to a 1″ diameter disk; GBC HeatLaminating films (# 3000038 clear polyester substrate with homopolymeradhesive) are cut to 1.69″ in diameter. Two pieces of the interfacingmaterial are dipped in the L-Glycine solution so as to saturate thefabrics with the solution. The saturated fabric disks are thensandwiched and placed between separate layers of the heat laminatingfilm (the saturated disks are separated from one another by plasticfilms), and the structure is sealed with a heating surface so as to formthe completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 15% onaverage when using this formulation as opposed to not using thesepatches.

Example 13

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Isoleucine, 150 mg of L-Leucine and 150 mg of L-Valine areadded to 30 ml of distilled water; A Pellon 100% polyester material iscut to a 1″ diameter disk; GBC Heat Laminating films (# 3000038 clearpolyester substrate with homopolymer adhesive) are cut to a 1.69″ indiameter. Two pieces of the interfacing material are dipped in the aminoacid solution so as to saturate the fabrics with the solution. Thesaturated fabric disks are then sandwiched and placed between separatelayers of the heat laminating film (the saturated disks are separatedfrom one another by plastic films), and the structure is sealed with aheating surface so as to form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 25% onaverage when using this formulation as opposed to not using thesepatches.

Example 14

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Methionine is added to 15 ml of distilled wafer; A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the L-Methionine solution so as tosaturate the fabrics with the solution. The saturated fabric disks arethen sandwiched and placed between separate layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests if wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches.

Example 15

Patch 400 of the invention having Left-Handed molecules may bemanufactured with the following specifications:

500 mg of L-Taurine is added to 15 ml of distilled water; A Pellon 100%polyester interfacing material is cut to a 1″ diameter disk; GBC HeatLaminating films (# 3000038 clear polyester substrate with homopolymeradhesive) are cut to 1.69″ in diameter. Two pieces of the interfacingmaterial are dipped in the L-Taurine solution so as to saturate thefabrics with the solution. The saturated fabric disks are thensandwiched and placed between separate layers of the heat laminatingfilm (the saturated disks are separated from one another by plasticfilms), and the structure is sealed with a heating surface so as to formthe completed structure.

Patch 400 of the invention having Right-Handed molecules may bemanufactured with the following specifications:

Honey in its raw form (Sioux Honey) and unsulphured Molasses (GrandmaMolasses) is utilized as the patch ingredient. The ratio of Honey toMolasses is 3 lb. of honey by weight to 355 ml of Molasses. A Pellon100% polyester interfacing material is cut to a 1″ diameter disk; GBCHeat Laminating films (# 3000038 clear polyester substrate withhomopolymer adhesive) are cut to 1.69″ in diameter. Two pieces of theinterfacing material are dipped in the Honey/Molasses solution so as tosaturate the fabric with the solution. The honey/molasses-saturatedfabric disks are then sandwiched and placed between layers of the heatlaminating film (the saturated disks are separated from one another byplastic films), and the structure is sealed with a heating surface so asto form the completed structure.

The above patches were tested with users by placing patch 400 havingLeft-Handed molecules on the right arms and patch 400 havingRight-Handed molecules on the left arms; it was found that when using ahand dynamometer there was an average 10% increase in hand strength whenusing these patches as opposed to not using them. In other tests it wasfound that strength endurance (stamina) was increased over 20% onaverage when using this formulation as opposed to not using thesepatches.

Example 16

The invention provides a new supplement and method for the improvementof athletic performance, and more particularly a means by which anindividual may increase their net stamina/strength endurance output. Toquantitatively assess the effectiveness of the invention in improvingthe bench press performance of fatigued college football athletes duringteam training, a double-blind placebo controlled study was implementedat Morehouse College in Atlanta, Ga., with 44 college athletes from theschool's football team volunteering to participate in this study. Inmost evaluations of strength endurance involving competitive athletes,it is common and customary to perform both baseline and comparativetests prior to the athlete having performed any other type of physicalactivity. In this study, both baseline and comparative data werecollected after the athletes had been fatigued by a 60-minute heavyweight-training workout. In addition, it was also decided to test theathletes while under heavy physical trauma. The athletes performed theworkout and tests starting at 4:30 a.m. in a weight training room wherethe temperature was maintained in excess of 95° F. The standardizedexercise that was chosen for this test was a 185 pound or 225 poundbench press.

Using a double-blind randomized placebo controlled study, a total of 44subjects, ages 18 to 30 years, volunteered to participate for thisstudy. Subjects' baseline bench press data was collected after a normalprescribed off-season football upper body 60-minute workout session.Subjects were asked to bench press a fixed weight until failure.

In the next session, subjects were randomized into three groups using anumbering system that labeled participants as experiment group, placebogroup or control group members with 44 completing this two-sessionstudy. The placebo group was provided with dermal patches that hadplacebo water formula. The experimental group was provided withexperimental dermal patches. The experimental dermal patches includedeither patch 400 having Left-Handed molecules or patch 400 havingRight-Handed molecules or both. In the experimental group, patch 400having left-handed molecules was placed on the palm side of the rightforearm of the participants, and patch 400 having right-handed moleculeswas placed on palm side of the left forearm of the participants. In theplacebo group, placebo dermal patches were placed on palm sides of boththe left arm and the right arm of the participants. A collection teamindependent of the players collected and monitored data throughout thestudy process.

Data collected from the two-day study was as follows. All numbers listedare repetitions performed:

CONTROL GROUP PLACEBO GROUP EXPERIMENT GROUP Baseline Comparative %Change Baseline Comparative % Change Baseline Comparative % Change 6 4−33 8 8 0 12 10 −17 10 12 20 7 8 14 1 3 200 9 11 22 5 6 20 6 12 100 5 50 4 3 −25 4 6 50 12 12 0 6 3 −50 2 3 50 10 10 0 15 18 20 5 3 −40 10 9−10 12 10 −17 9 9 0 2 3 50 11 13 18 11 15 36 3 0 −100 12 12 0 3 4 33 4 40 7 10 43 18 16 −11 10 12 20 16 21 31 15 16 7 5 4 −20 20 23 15 6 9 50 109 −10 9 7 −22 16 16 0 5 5 0 4 5 25 15 15 0 8 10 25 10 11 10

From the data collected in the above table, it was determined that (1)the average percentage change in strength endurance in the Control groupwas a decrease in performance of 3.1% from the baseline tests to thecomparative tests; (2) the average percentage change in strengthendurance in the Placebo group was increase in performance of 3.6% fromthe baseline tests to the comparative tests; (3) the average percentagechange in strength endurance in the Experiment group was an increase inperformance of 33.9% from the baseline tests to the comparative tests.

In addition, the data shows the following:

CONTROL GROUP PLACEBO GROUP EXPERIMENT GROUP Decrease Same IncreaseDecrease Same Increase Decrease Same Increase 5 6 5 4 2 7 3 2 10

In the Control group, applicants found that 31.25% of the participantsshowed a decrease in performance during the two-day study, 37.5% of theparticipants maintained the same level of performance during the two-daystudy, and 31.25% of the participants showed an increase in performanceduring the two-day study. In the Placebo group, applicants found that30.8% of the participants showed a decrease in performance during thetwo-day study, 15.4% of the participants maintained the same level ofperformance during the two-day study, and 53.8% of the participantsshowed an increase in performance during the two-day study. In theExperiment group, applicants found that 20% of the participants showed adecrease of performance during the two-day study, 13.33% of theparticipants maintained the same level of performance during the two-daystudy, and 66.67% of the participants showed an increase in performanceduring the two-day study.

After removing the data for the individuals who both decreased inperformance and maintenance the same level of performance, applicantsfound that (1) in the Control group, with respect to the 5 individualswho did show an improvement in performance from the baseline to thecomparative test, the average increase in strength endurance was 24.4%;(2) in the Placebo group, with respect to the 7 individuals who did showan improvement in performance from the baseline to the comparative test,the average increase in strength endurance was 23%; (3) in theExperimental group, with respect to the 10 individuals who did show animprovement in performance from the baseline to the comparative test,the average increase in strength endurance was 57.6%.

After removing the data for the individuals who both increased inperformance and maintained the same level of performance, applicantsfound that (1) in the Control group, with respect to the 5 individualswho decreased in performance from has baseline to the comparative test,the average decrease in strength endurance was 34.6%; (2) in the Placebogroup, with respect to the 4 individuals who decreased in performancefrom the baseline to the comparative test, the average decrease instrength endurance was 28.5%; (3) in the Experiment group, with respectto the 3 individuals who decreased in performance from the baseline tothe comparative test, the average decrease in strength endurance was22.67%.

Based on the data collected, it is evident that there are severaldistinct differences in athletic performance between the three testgroups. With respect to the simple averaging of performance numbers, itis not unusual that the Control group experienced a decrease in strengthendurance given the nature of the test (baseline data collected on aMonday and comparative data collected on a Thursday; data collectedafter athletes were fatigued). With respect to the Placebo group, a casecould be made that there was indeed a “Placebo effect” that took place;athletes that wore the patch product thought that they had the realtechnology so, hence, they made more of an effort to perform. Given thedata of the average group performance improvement of 3.6%, this would bea reasonable spread in terms of attainable improvements from thebaseline day to the comparative day. With respect to the Experimentgroup, a case could be made that there was indeed a significant effectof the experimental dermal patch on athletic performance; athletes thatwore the patch product experienced an average improvement of 33.9% instrength performance. The spreads in average performance numbers betweenthe three groups is significant and would tend to indicate that theexperimental dermal patch played an important role in improving strengthendurance in the experiment group.

Another indicator that the experimental dermal patch was having asignificant effect on athletic stamina is evidenced in the chart. Ascould be expected, in the Control group, there is an almost evendistribution between athletes that decreased in performance, athletesthat remained the same in performance, and athletes that improved inperformance. In the Placebo group, 7 individuals improved in performanceas compared to 5 in the Control group. However, given the low averageimprovement in members and the well-known “Placebo effect,” this spreadis anticipated. In the Experiment group, only 3 members decreased inperformance, with 10 members improving in strength endurance. Given thatthe Experiment group had the highest percentage of members who recordedan improvement in performance, with two-thirds of the membersdemonstrating an improvement, and that the average improvement wassignificantly higher than the other two groups (33.9%), this would againindicate that the experimental dermal patch was having a beneficialeffect on athletic performance. Another potentially important indicatorwith respect to examining whether or not the experimental dermal patchwas having a beneficial effect on athletic performance is found whenlooking at only those individuals who increased in performance or onlythose individuals who decreased in performance. In the Control group,applicants found that of those individuals how did show an improvement,the average gain was 24.4%; of those in the Control group who decreasedin performance, the average decline in performance was 34.6%. In thePlacebo group, applicants found that of those individuals who did showan improvement, the average gain was similar to the Control group at23%; of those in the Placebo group who decreased in performance,applicants found that the average decline in performance was 28.5%. Inthe Experiment group, applicants found that of those individuals who didshow an improvement, the average gain was more than double of the othertwo groups at 57.6%; of the three individuals who showed a decrease inperformance, the average decline in performance was the lowest of thethree groups at 22.67%. This information clearly indicates that theexperimental dermal patch was having a beneficial effect on strengthendurance.

Based on the data collected and the results obtained, it wasdemonstrated that the invention (i.e., experimental dermal patch)provides a method for the improvement of athletic performance, and moreparticularly a means by which an individual may increase their netstamina/strength endurance output. It was also demonstrated that theExperiment group using the invention (i.e., experimental dermal patchshowed the highest percentage of improvement in strength endurance whenaveraging all members, the highest percentage of improvement in strengthendurance when averaging only those members who showed an improvement,and the lowest percentage of decreased performance when averaging onlythose individuals who showed a decline in performance.

Example 17

The invention provides a new supplement and method for the improvementof athletic performance, and more particularly a means by whichindividuals may substantially increase their net strength endurancewithin as quickly as the first use of the product. To quantitativelyassess the effectiveness of the invention in improving the bench pressperformance of college football athletes during team training, adouble-blind placebo controlled study was implemented at Troy StateUniversity in Troy, Ala. A standardized test was selected to measure netgains in strength endurance, and in this case the exercise that wasperformed by all athletes was a 225 pound flat bench press. The baselinedata for this test was collected on Thursday Jun. 26, 2003. Thecomparative data was collected on the following Wednesday Jul. 2, 2003.Athletes were divided into three groups; Control, Placebo and Test. TheControl group was tested “as is” on both of these testing days. ThePlacebo group was given a set of patches filled with water; this groupwas unaware as to whether or not the patches were real or water filled.The Test group was given a set of patches of the invention; again, thisgroup was unaware as to the contents of the patches. It should beemphasized that the athletes used the patches of the invention onlyonce; the test was performed within 10 minutes of first applying thepatches to the athletes.

Using a double-blind randomized placebo controlled study, a total of 25subjects, ages 18 to 22 years, volunteered to participate for this teststudy. Subjects' baseline bench press data was collected after a briefwarm up period. Subjects were asked to bench press a lived 225 poundweight until failure. In the next session, subjects were randomized intothree groups using a numbering system that labeled participants as Testgroup, Placebo group or Control group members with 25 completing thistwo-session study. The Test group was provided with non-transdermalpatches that included either patch 400 having Left-Handed molecules orpatch 400 having Right-Handed molecules or both. In the test group,patch 400 having left-handed molecules was placed on the palm side ofthe right forearm of the participants, and patch 400 having right-handedmolecules was placed on palm side of the left forearm of theparticipants. The Placebo group was provided with non-transdermalpatches that contained water. In the placebo group, placebo dermalpatches were places on palm sides of both the left arm and the right armof the participants. A collection team independent of the playerscollected and monitored data throughout the study process.

Data collected from the two-day study was as follows; all numbers listedare repetitions performed:

CONTROL PLACEBO TEST Baseline Comparative {circumflex over ( )}Reps{circumflex over ( )}Percent Baseline Comparative {circumflex over( )}Reps {circumflex over ( )}Percent Baseline Comparative {circumflexover ( )}Reps {circumflex over ( )}Percent 10 10 0 0 23 23 0 0 3 8 +5+166.7%  4 6 +2   +50% 10 10 0 0 16 15 −1  −6.2% 12 14 +2 +16.7% 7 12 +5+71.4% 8 9 +1 +12.5% 9 10 +1 +11.1% 21 24 +3 +14.3% 16 18 +2 +12.5% 1013 +3   +30% 14 8 −6 −42.8% 7 15 +8 +114.3%  5 6 +1   +20% 10 11 +1  +10% 5 8 +3   +60% 20 21 +1  +4.7% 26 27 +1  +3.8% 12 14 +2 +16.7% 1819 +1  +5.5% 11 17 +6 +54.5% 6 5 −1 −16.7% 18 11 −7 −38.9%

From the date collected in the above table, and by removing the highestand lowest scores from each group, it was determined that (1) theaverage percentage change in strength endurance in the Control group wasan increase in performance of 8.9% from the baseline tests to thecomparative tests (average 0.875 rep improvement); (2) the averagepercentage change in strength endurance in the Placebo group was anincrease in performance of 13.8.% from the baseline tests to thecomparative tests (average 1.67 rep improvement); and (3) the averagepercentage change in strength endurance in the Test group was anincrease in performance of 43.2% from the baseline tests to thecomparative tests (average 2.6 rep improvement).

In addition, the data shows the following:

CONTROL GROUP PLACEBO GROUP TEST GROUP Decrease Same Increase DecreaseSame Increase Decrease Same Increase 2 1 7 1 2 5 1 0 6

The above table provides the breakdown of athletes in each group as itpertains to showing whether or not an athlete showed a decrease inperformance from baseline to comparative test, remained the same inperformance from baseline to comparative test, or showed an increase inperformance from baseline to comparative test.

In the Control group, Applicants found that 20% of the participantsshowed a decrease in performance during the two-day study, 10% of theparticipants maintained the same level of performance during the two-daystudy, and 70% of the participants showed an increase in performanceduring the two-day study. In the Placebo group, Applicants found that12.5% of the participants showed a decrease in performance during thetwo-day study, 25% of the participants maintained the same level ofperformance during the two-day study, and 62.5% of the participantsshowed an increase in performance during the two-day study. In the Testgroup, Applicants found that 14.3% of the participants showed a decreasein performance during the two-day study, 0% of the participantsmaintained the same level of performance during the two-day study, and85.7% of the participants showed an increase in performance during thetwo-day study.

After removing the data for the individuals who both decreased inperformance and maintained the same level of performance, Applicantsfound that (1) in the Control group, with respect to the 7 individualswho did show an improvement in performance from the baseline to thecomparative test, the average increase in strength endurance was 19.7%;(2) in the Placebo group, with respect to the 5 individuals who did showan improvement in performance from the baseline to the comparative test,the average increase in strength endurance was 30.8%; (3) in the Testgroup, with respect to the 6 individuals who did show an improvement inperformance from the baseline to the comparative test, the averageincrease in strength endurance was 63.8%.

After removing the data for individuals who both increased inperformance and maintained the same level of performance. Applicantsfound that (1) in the Control group, with respect to the 2 individualswho decreased in performance from the baseline to the comparative test,the average decrease in strength endurance was 27.8%; (2) in the Placebogroup, with respect to the 1 individual who decreased in performancefrom the baseline to the comparative test, the decrease in strengthendurance was 42.8%; (3) in the Experiment group, with respect to the 1individual who decreased in performance from the baseline to thecomparative test, the decrease in strength endurance was 6.2%.

Based on the data collected, it is evident that there are severaldistinct differences in athletic performance between the three groups.With respect to the simple averaging of performance numbers, it is notunusual that all three groups experienced an increase in strengthendurance given the nature of the test (athletes were in a trainingsession for the upcoming football season). With respect to the Placebogroup, a case could be made that there was indeed a “Placebo Effect”that took place; athletes that wore the patch product thought that theyhad the real technology so hence they made more of an effort to perform.Given the data of the average group performance improvement of thePlacebo group of 13.8% (as compared to 8.9% in the Control group), thiswould be a reasonable spread in terms of attainable improvements fromthe baseline day to the comparative day. With respect to the Test group,there was indeed a significant effect of the test dermal patch onathletic performance; athletes that wore the patch product experiencedan average improvement of 43.2% in strength performance. The spreads inaverage performance numbers between the three groups is significant andwould tend to indicate that the test dermal patch played an importantrole in improving strength endurance in the test group.

Another indicator that the test dermal patch was having a significanteffect on athletic stamina is evidenced in the Table. In all threegroups, Applicants found that the majority of the athletes improved inperformance; however, the Control group and Placebo group showed nearlyidentical percentages of athletes that improved, with 70% of the Controlgroup and 62.5% of the Placebo group. By comparison in the Test group,Applicants found that 85.7% of the participants experienced animprovement in performance. Given that the Test group had the highestpercentage of members who recorded an improvement in performance, with85.7% of the members demonstrating an improvement, and that the averageimprovement was significantly higher than the other two groups (43.2%)this would again indicate that the test dermal patch was having abeneficial effect on athletic performance.

Another important indicator with respect to examining that the testdermal patch was having a beneficial effect on athletic performance isfound when looking at only those individuals who increased inperformance or only those individual who decreased in performance. Inthe Control group, Applicants found that, of those individuals who didshow an improvement, the average gain was 19.7%. In the Placebo group,Applicants found that, of those individuals who did show an improvement,the average gain was close to the Control group at 30.8%. In the Testgroup, Applicants found that, or those individuals who did show animprovement, the average gain was more than triple the Control group anddouble the Placebo group at 63.8%. This information would indicate thatthe test dermal patch was having a beneficial effect on strengthendurance. This improvement is dramatic in that the individuals testedhad only used the test dermal patch for 10 minutes prior to the test.

Based on the data collected and the results obtained it was demonstratedthat the invention (i.e., test dermal patch) provides a method forimprovement of athletic performance, and more particularly a means bywhich an individual may increase their net stamina/strength enduranceoutput. The model utilized to evaluate the technology was a double-blindplacebo controlled study, with 25 college athletes from the Troy StateUniversity football team volunteering to participate in this study. Inthis evaluation of strength endurance involving competitive athletesboth baseline and comparative tests were performed prior to any othertype of physical activity.

It was demonstrated that the group using the invention (i.e., testdermal patch) showed the highest percentage of improvement in strengthendurance when averaging all members, the highest percentage ofimprovement in strength endurance when averaging only those members whoshowed an improvement, and the lowest percentage of decreasedperformance when averaging only those individuals who showed a declinein performance.

While a particular embodiment of the present invention has beendescribed, it is to be understood that modifications will be apparent tothose skilled in the art without departing from the spirit of theinvention. The scope of the invention, therefore, is to be determinedsolely by the following claims.

1-57. (canceled)
 58. A system configured to be applied to a subject'sbody to provide a beneficial biological effect for the subject, theapparatus comprising at least one Left-Handed organicmaterial-containing apparatus and at least one Right-Handed organicmaterial-containing apparatus configured to be simultaneously applied toa subject's body: A. the at least one Left-Handed organicmaterial-containing apparatus is configured to be applied to a firstposition on a subject's body and comprises: 1 at least one organicmaterial including a Left-Handed molecule; 2 at least one substrate forthe at least one organic material; and 3 at least one enclosure for theat least one organic material and the at least one substrate; and B. theat least one Right-Handed organic material-containing apparatus isconfigured to be applied to a second position on a subject's bodyseparate and distinct from the first position and comprises 1 at leastone organic material including a Right-Handed molecule; 2 at least onesubstrate for the at least one organic material; and 3 at least oneenclosure for the at least one organic material and the at least onesubstrate, wherein the at least one Left-Handed organicmaterial-containing apparatus and the at least one Right-Handed organicmaterial-containing apparatus together provide the beneficial biologicaleffect, and wherein the at least one enclosure for both the at least oneLeft-Handed organic material-containing apparatus and the at least oneRight-Handed organic material-containing apparatus comprises an adhesivefor adhering the at least one enclosure to the subject's body andwherein the at least one enclosure is comprised of one or more materialsthat prevent the at least one organic material from direct contact withthe subject's body while the at least one enclosure is adhered to thesubject's body.
 59. The system of claim 58, wherein the Left-Handedorganic material-containing apparatus comprises a plurality ofLeft-Handed molecules.
 60. The system of claim 58, wherein theRight-Handed organic material-containing apparatus comprises a pluralityof Right-Handed molecules.
 61. The system of claim 58, wherein theLeft-Handed molecule is an amino acid selected from the group consistingof L-Alanine, L-Arginine, L-Aspargine, L-Aspartic Acid, L-Carnitine,Acetyl-L-Carnitine, L-Carnitine L-Tartrate, L-Carnitine MagnesiumCitrate, L-Citrulline, L-Cysteine, L-Cystine, L-GABA, L-Glutamic Acid,L-Glutamine, Glutathione Peroxidase, L-Glycine, L-Histidine,Hydroxyglutamic Acid, Hydroxyproline, L-Isoleucine, L-Leucine,Norleucine, L-Lysine, L-Methionine, L-Ornithine, L-Valine,L-Phenylalanine, L-Proline, L-Serine, L-Taurine, L-Threonine,L-Tryptophan, and L-Tyrosine.
 62. The system of claim 58, wherein theRight-Handed molecule is an amino acid selected from the groupconsisting of D-Alanine, D-Arginine, D-Aspargine, D-Aspartic Acid,D-Carnitine, Acetyl-D-Carnitine, D-Carnitine D-Tartrate, D-CarnitineMagnesium Citrate, D-Citrulline, D-Cysteine, D-Cystine, D-GABA,D-Glutamic Acid, D-Glutamine, D-Glutathione Peroxidase, D-Glycine,D-Histidine, D-Hydroxyglutamic Acid, D-Hydroxyproline, D-Soleucine,D-Leucine, D-Norleucine, D-Lysine, D-Metbionine, D-Ornithine, D-Valine,D-Phenylalanine, D-Proline, D-Serine, D-Taurine, D-Threonine,D-Tryptophan, and D-Tyrosine.
 63. The system of claim 58, wherein theRight-Handed molecule is a sugar, wherein the sugar is selected from agroup consisting of dextrin, dextrose, fructose, galactose, glucose,glycogen, inositol, invert sugar, lactose, levulose, maltose, molasses,sucrose, xylose, and mixtures thereof.
 64. The system of claim 58,wherein the Left-Handed molecule is an amino acid, wherein the aminoacid is selected from the group consisting of L-Arginine, L-Carnitine,Acetyl-L-Carnitine, L-Carnitine L-Tartrate, L-Carnitine MagnesiumCitrate, L-Glutamine, L-Methionine, L-Ornithine, and L-Taurine.
 65. Thesystem of claim 58, wherein the Left-Handed molecule is an amino acidselected from the group consisting of L-Carnitine, Acetyl-L-Carnitine,L-Carnitine L-Tartrate, and L-Carnitine Magnesium Citrate.
 66. Thesystem of claim 58, wherein the Right-Handed molecule is a sugar,wherein the sugar is in a form selected from a group consisting ofhoney, molasses and sugar cane.
 67. The system of claim 58, wherein theat least one substrate in the Left-Handed organic molecule-containingapparatus and/or the at least one substrate in the Right-Handed organicmolecule-containing apparatus is polyester or cotton.
 68. The system ofclaim 58, wherein the at least one enclosure in the Left-Handed organicmolecule-containing apparatus and/or the at least one enclosure in theRight-Handed organic molecule-containing apparatus is made of a plasticfilm selected from the group consisting of polyethylene, polypropylene,ABS, plexiglass, lexan, light polarizing film, and linear low densityfilm.
 69. The system of claim 58, wherein the in the Left-Handed organicmolecule-containing apparatus and/or the a Right-Handed organicmolecule-containing apparatus further comprises one or more adhesiveportions configured to permit attachment of the apparatus to a skinsurface of the subject.
 70. The system of claim 69, wherein the one ormore adhesive portions includes a medical grade adhesive.
 71. The systemof claim 58, wherein the first position is an electrically positivepoint on the body, and wherein the second position is an electricallynegative point on the body.
 72. The system of claim 58, wherein thefirst position is a YANG acupuncture point on the body, and wherein thesecond position is a YIN acupuncture point on the body.
 73. The systemof claim 58, wherein the Left-Handed organic molecule-containingapparatus and/or the Right-Handed organic molecule-containing apparatusfurther comprises one or more additives for the at least one organicmaterial that are selected from the group consisting of Glycerin,d-calcium pantothenate, sorbitol, propylparaben, potassium sorbate,methylparaben, and Colloidal Gold.
 74. The system of claim 58, whereinthe Left-Handed organic molecule-containing apparatus is a patchconstructed in layers, the layers comprising a plastic film or a lightpolarizing film as an enclosure, a polyester fabric as a substrate,Water, L-Carnitine, Glycerin, d-calcium pantothenate, sorbitol,propylparaben, potassium sorbate, and methylparaben, and wherein theRight-Handed organic molecule-containing apparatus is a patchconstructed in layers, the layers comprising a plastic film or a lightpolarizing film as an enclosure, a polyester fabric as a substrate,honey, and molasses.
 75. A method of providing a beneficial biologicaleffect for a subject, the method comprising: A. applying at least oneLeft-Handed organic material-containing apparatus to a first position onthe subject's body, the apparatus comprising 1 at least one organicmaterial including a Left-Handed molecule; 2 at least one substrate forsaid at least one organic material; and 3 at least one enclosure forsaid at least one organic material and said at least one substrate; andB. applying at least one Right-Handed organic material-containingapparatus for application to a second position on the subject's bodyseparate and distinct from the first position, the apparatus comprising1 at least one organic material including a Right-Handed molecule; 2 atleast one substrate for said at least one organic material; and 3 atleast one enclosure for said at least one organic material and said atleast one substrate.